South San Francisco, CA, United States of America

Cheng-Ting Tsai

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Enable Biosciences Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cheng-Ting Tsai. Retrieved from https://idiyas.com/inventor/cheng-ting-tsai-lsghlljk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Cheng-Ting Tsai

Introduction

Cheng-Ting Tsai is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of nucleic acid research, holding two patents that focus on innovative methods and reagents.

Latest Patents

His latest patents include "Reagents and methods for blocking non-specific interactions with nucleic acids." This invention discloses methods and reagents designed to block non-specific interactions with nucleic acids. In particular, it relates to multi-valent blockers that comprise multiple negatively charged polymers or materials attached to a common scaffold. These blockers are essential for preventing non-specific interactions with nucleic acids, enhancing the reliability of various biochemical applications.

Career Highlights

Cheng-Ting Tsai is associated with Enable Biosciences Inc., where he continues to develop groundbreaking technologies. His work has been instrumental in advancing the understanding and manipulation of nucleic acids, which are crucial for numerous scientific and medical applications.

Collaborations

One of his notable coworkers is Peter Robinson, with whom he collaborates on various projects aimed at enhancing nucleic acid research.

Conclusion

Cheng-Ting Tsai's innovative work in the field of nucleic acids has led to significant advancements, making him a valuable contributor to scientific research and development. His patents reflect a commitment to improving methodologies in this critical area of study.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…